Cellebrite DI Ltd (NASDAQ: CLBT) is 135.68% higher on its value in year-to-date trading and has touched a low of $7.91 and a high of $21.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CLBT stock was last observed hovering at around $20.23 in the last trading session, with the day’s gains setting it 0.18%.
Currently trading at $20.41, the stock is 1.06% and 7.23% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.25 million and changing 0.89% at the moment leaves the stock 40.51% off its SMA200. CLBT registered 147.69% gain for a year compared to 6-month gain of 70.08%. The firm has a 50-day simple moving average (SMA 50) of $18.989 and a 200-day simple moving average (SMA200) of $14.48185.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 16.83% loss in the last 1 month and extending the period to 3 months gives it a 17.03%, and is 0.10% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.55% over the week and 3.81% over the month.
Cellebrite DI Ltd (CLBT) has around 1008 employees, a market worth around $4.25B and $385.17M in sales. Fwd P/E is 78.93. Profit margin for the company is -82.28%. Distance from 52-week low is 158.03% and -6.03% from its 52-week high. The company has generated returns on investments over the last 12 months (-103.53%).
The EPS is expected to shrink by -218.60% this year
217.0 institutions hold shares in Cellebrite DI Ltd (CLBT), with institutional investors hold 99.56% of the company’s shares. The shares outstanding are 208.08M, and float is at 86.02M with Short Float at 1.69%. Institutions hold 52.97% of the Float.
The top institutional shareholder in the company is TRUE WIND CAPITAL MANAGEMENT, L.P. with over 13.39 million shares valued at $159.98 million. The investor’s holdings represent 6.8018 of the CLBT Shares outstanding. As of 2024-06-30, the second largest holder is CLAL INSURANCE ENTERPRISES HOLDINGS LTD with 7.65 million shares valued at $91.47 million to account for 3.8892 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 6.99 million shares representing 3.5519 and valued at over $83.54 million, while NINE TEN CAPITAL MANAGEMENT LLC holds 1.9935 of the shares totaling 3.92 million with a market value of $46.89 million.
Cellebrite DI Ltd (CLBT) Insider Activity
Still, SEC filings show that on Dec 09 ’24, NADINE BAUDOT-TRAJTENBERG (Director) Proposed Sale 35,223 shares at an average price of $20.24 for $0.71 million. The insider now directly holds shares of Cellebrite DI Ltd (CLBT).
